Header Artwork
Header Artwork



Understanding the Power of the FDA Pre-Sub: Tips for a Successful Meeting

Published Date: September 30, 2020

The submission process to the FDA can be a stressful and uncertain time for a medical device company. Delays in getting your device to market can cost millions of dollars in revenue. Changes to standards, new guidance documents, and review variability all add to the stress of a submission. The FDA pre-submission process can help reduce the stress and answer questions related to your specific device.

In this webinar, we will cover what the pre-submission process is, how to initiate a meeting, and how to prepare and run the meeting to gain the best results. We will highlight tips we have used to make partnering with the FDA a rewarding experience.

Join Thor Rollins and Matthew Jorgensen; PhD, DABT, as they cover:

  • What is a pre-submission meeting (Q-sub) with the FDA?
  • How do you set a Q-Sub?
  • How do you deliver your plan during a Q-Sub?
  • What is the meeting flow?
  • Can I challenge the FDA?
  • How do I get the most from the Q-Sub?
Thor Rollins

Thor Rollins

Biocompatibility Expert

Thor Rollins is a certified microbiologist and specializes in the selection and conduct of in vitro and in vivo biocompatibility tests. He actively speaks on biocompatibility related topics through Nelson Labs’ external seminars, webinars, and tradeshows. He presented on biocompatibility at the American College of Toxicology annual meeting in 2013 and has published many articles...

Complete the following information to access the webinar